Enhanced arteriolar α-adrenergic constriction impairs dilator responses and skeletal muscle perfusion in obese Zucker rats

Journal of Applied Physiology

Volumn 97, Issue 2, 2004, Pages 764-772

  Frisbee, Jefferson C ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Models of metabolic syndrome X; Obesity; Regulation of vascular tone; Skeletal muscle blood flow regulation; Skeletal muscle perfusion

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR; CHOLESTEROL; CLONIDINE; GLUCAGON; GLUCOSE; INSULIN; LEPTIN; NORADRENALIN; PHENTOLAMINE; PHENYLEPHRINE; PRAZOSIN; TRIACYLGLYCEROL; YOHIMBINE;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ARTERY DIAMETER; ARTERY DILATATION; ARTICLE; BLOOD VESSEL TONE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CREMASTER MUSCLE; GASTROCNEMIUS MUSCLE; GRACILIS MUSCLE; MALE; METABOLIC SYNDROME X; MUSCLE BLOOD FLOW; MUSCLE PERFUSION; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; RESISTANCE BLOOD VESSEL; SKELETAL MUSCLE;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; ARTERIOLES; CLONIDINE; MALE; METABOLIC SYNDROME X; MUSCLE, SKELETAL; OBESITY; PHENYLEPHRINE; PRAZOSIN; RATS; RATS, ZUCKER; RECEPTORS, ADRENERGIC, ALPHA; REGIONAL BLOOD FLOW; VASOCONSTRICTOR AGENTS; VASODILATION;

EID: 3242734728     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/japplphysiol.01216.2003     Document Type: Article

References (47)

1. American Heart Association. Statistical Fact Sheets: "Risk Factors". http://www.americanheart.org/presenter.jhtml?identifier=2016, April 16, 2003.
2. American Diabetes Association. National Diabetes Fact Sheet. http://www.diabetes.org/diabetes-statistics.jsp, April 16, 2003.
3. Anderson KM and Faber JE. Differential sensitivity of arteriolar alpha 1- and alpha 2-adrenoreceptor constriction to metabolic inhibition during rat skeletal muscle contraction. Circ Res 69: 174-184, 1991.
4. Baker M and Wayland H. On-line volume-flow rates and velocity profile measurements for blood in microvessels. Microvasc Res 7: 131-143, 1974.
5. Bray GA. The Zucker-fatty rat: a review. Fed Proc 36: 148-153, 1977.
6. Bray GA and York DA. Genetically transmitted obesity in rodents. Physiol Rev 51: 598-646, 1971.
7. Carlson SH, Shelton J, White CR, and Wyss JM. Elevated sympathetic activity contributes to hypertension and salt sensitivity in diabetic obese Zucker rats. Hypertension 35: 403-408, 2000.
8. Dinenno FA and Joyner MJ. Blunted sympathetic vasoconstriction in contracting skeletal muscle of healthy humans: is nitric oxide obligatory? J Physiol 553: 281-292, 2003.
9. Faber JE. In situ analysis of alpha-adrenoreceptors on arteriolar and venular smooth muscle in rest skeletal muscle microcirculation. Circ Res 62: 37-50, 1988.
10. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Olegginni M, Graziadei L, Pedrinelli R, Brandi L, and Bevilacqua S. Insulin resistance and essential hypertension. N Engl J Med 317: 350-357, 1987.
11. 2. Am J Physiol Heart Circ Physiol 267: H706-H715, 1994.
12. Frisbee JC. Impaired dilation of skeletal muscle resistance arteries to reduced oxygen tension in the diabetic obese Zucker rat. Am J Physiol Heart Circ Physiol 281: H1568-H1574, 2001.
13. Frisbee JC. Impaired skeletal muscle perfusion in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol 285: R1124-R1135, 2003.
14. Frisbee JC. Regulation of in situ skeletal muscle arteriolar tone: interactions between two parameters. Microcirculation 9: 443-462, 2002.
15. Frisbee JC. Remodeling of the skeletal muscle microcirculation increases resistance to perfusion in obese Zucker rats. Am J Physiol Heart Circ Physiol 285: H104-H111, 2003.
16. Frisbee JC, Maier KG, and Stepp DW. Elevated oxidant stress contributes to enhanced myogenic activation of skeletal muscle microvessels of obese Zucker rats Am J Physiol Heart Circ Physiol 283: H2160-H2168, 2002.
17. Frisbee JC, Maier KG, Falck JR, Roman RJ, and Lombard JH. Integration of hypoxic dilation signaling pathways for skeletal muscle resistance arteries. Am J Physiol Regul Integr Comp Physiol 283: R309-R319, 2002.
18. Frisbee JC and Stepp DW. Impaired nitric oxide-dependent dilation of skeletal muscle arterioles in diabetic obese Zucker rats. Am J Physiol Heart Circ Physiol 281: H1304-H1311, 2001.
19. Grassi G, Seravalle G, Cattaneo BM, Bolla GB, Lanfranchi A, Colombo M, Giannattasio C, Brunani A, Cavagnini F, and Mancia G. Sympathetic activation in obese normotensive subjects. Hypertension 25: 560-563, 1995.
20. Greene AS, Tonellato PJ, Liu J, Lombard JH, and Cowley AW Jr. Microvascular rarefaction on tissue vascular resistance in hypertension. Am J Physiol Heart Circ Physiol 256: H126-H131, 1989.
21. Guerre-Millo M. Regulation of ob gene and overexpression in obesity. Biomed Pharmacother 51: 318-323, 1997.
22. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, and Stern MP. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 41: 715-722, 1992.
23. Hamman JJ, Buckwalter JB, Valic Z, and Clifford PC. Sympathetic restraint of muscle blood flow at the onset of dynamic exercise. J Appl Physiol 92: 2452-2456, 2002.
24. Hansen J, Sayad D, Thomas GD, Clarke GD, Peshock RM, and Victor RG. Exercise-induced attenuation of alpha-adrenoreceptor mediated vasoconstriction in humans: evidence from phase-contrast MRI. Cardiovasc Res 41: 220-228, 1999.
25. Kannel WB, Brand N, Skinner JJ Jr, Dawber TR, and McNamara PM. The relation of adiposity to blood pressure and development of hypertension: the Framingham study. Ann Intern Med 67: 48-59, 1967.
26. Koller A and Kaley G. Endothelial control of shear stress and resistance in the skeletal muscle microcirculation. In: Flow-Dependent Regulation of Vascular Function, edited by Bevan JA, Kaley G, and Rubanyi GM. New York: Oxford University Press, p. 236-260, 1995.
27. Krieger DH and Landsberg L. Obesity and hypertension. In: Hypertension: Pathophysiology, Diagnosis and Management, edited by Laragh JH and Brenner BM. New York: Raven, p. 2367-2388, 1995.
28. Laight DW, Kengatharan KM, Gopaul NK, Anggard EE, and Carrier MJ. Investigation of oxidant stress and vasodepression to glyceryl trinitrate in the obese Zucker rat in vivo. Br J Pharmacol 125: 895-901, 1998.
29. Lash JM, Sherman WM, and Hamlin RL. Capillary basement membrane thickness and capillary density in sedentary and trained obese Zucker rats. Diabetes 38: 854-860, 1989.
30. Lombard JH, Hinojosa-Laborde C, and Cowley AW Jr. Hemodynamics and microcirculatory alterations in reduced renal mass hypertension. Hypertension 13: 128-138, 1989.
31. Mathe D. Dyslipidemia and diabetes: animal models. Diabetes Metab 21: 106-111, 1995.
32. Nambi V, Hoogwerf RJ, and Sprecher DL. A truly deadly quartet: obesity, hypertension, hypertriglyceridemia, and hyperinsulinemia. Cleve Clin J Med 69: 985-989, 2002.
33. O'Drobinak DM and Greene AS. Decreases in steady-state muscle performance and vessel density in reduced renal mass hypertensive rats. Ain J Physiol Heart Circ Physiol 270: H661-H667, 1996.
34. Ohyanagi M, Faber JE, and Nishigaki K. Differential activation of alpha 1- and alpha 2-adrenoreceptors on microvascular smooth muscle during sympathetic nerve stimulation. Circ Res 68: 232-244, 1991.
35. Ohyanagi M, Faber JE, and Nishigaki K. Interactions between microvascular alpha 1- and alpha 2-adrenoreceptors and endothelium-derived relaxing factor. Circ Res 71: 188-200, 1992.
36. Perterson DF, Armstrong RB, and Laughlin MH. Sympathetic neural influences on muscle blood flow in rats during submaximal exercise. J Appl Physiol 65: 434-440, 1998.
37. Reaven GM, Lithell H, and Landsberg L. Hypertension and associated metabolic abnormalities: the role of insulin resistance and the sympathoadrenal system. N Engl J Med 334: 374-381, 1996.
38. Ribeiro MM, Trombella IC, Batalha LT, Rondon MUPB, Forjaz CLM, Barretto ACP, Villares SMF, and Negrao CE. Muscle sympathetic nerve activity and hemodynamic alterations in middle aged obese women. Braz J Med Biol Res 34: 475-478, 2001.
39. 2-adrenergic vasoconstriction is blunted in contracting human muscle. J Physiol 547: 971-976, 2003.
40. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, and Baron AD. Obesity/insulin resistance is associated with endothelial dysfunction: implications for the syndrome of insulin resistance. J Clin Invest 97: 2601-2610, 1996.
41. Stepp DW, Pollock DM, and Frisbee JC. Low-flow remodeling in the metabolic syndrome X. Am J Physiol Heart Circ Physiol 286: H964-H970, 2004.
42. Stepp DW and Frisbee JC. Augmented α-adrenergic constrictor sensitivity in the skeletal muscle circulation of the obese Zucker rat. Am J Physiol Heart Circ Physiol 282: H816-H820, 2002.
43. Thomas GD, Hansen J, and Victor RG. ATP-sensitive potassium channels mediate contraction-induced attenuation of sympathetic vasoconstriction in rat skeletal muscle. J Clin Invest 99: 2602-2609, 1997.
44. Thomas GD and Victor RG. Nitric oxide mediates contraction-induced attenuation of sympathetic vasoconstriction in rat skeletal muscle. J Physiol 506: 817-826, 1998.
45. Tuck ML, Sowers J, Dornfeld L, Kledzik G, and Maxwell M. The effect of weight reduction on blood pressure, plasma renin activity and plasma aldosterone levels in obese patients. N Engl J Med 304: 930-933, 1981.
46. Tschakovsky ME, Sujirattanawimol K, Ruble SB, Valic Z, and Joyner MJ. Is sympathetic neural vasoconstriction blunted in the vascular bed of exercising human muscle? J Physiol 541: 623-635, 2002.
47. VanTeeffelen JW and Segal SS. Interaction between sympathetic nerve activation and muscle fiber contraction in resistance vessels of hamster retractor muscle. J Physiol 550: 563-574, 2003.